| Drug Name: | Nalbuphine (20594-83-6) |
|---|---|
| PubChem ID: | 5311304 |
| SMILES: | C1CC(C1)CN2CC[C@]34[C@@H]5[C@H](CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O)O |
| InchiKey: | NETZHAKZCGBWSS-CEDHKZHLSA-N |
| Therapeutic Category: | Analgesics, Central Nervous System Agents, Central Nervous System Depressants, Narcotic Antagonists, Narcotics, Peripheral Nervous System Agents, Sensory System Agents |
| Molecular Weight (dalton) | : | 357.45 |
| LogP | : | 1.7073 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 5 |
| Hydrogen Bond Donor Count | : | 3 |
| Total Polar Surface Area | : | 73.16 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category